Market Place
Sourcing Support
Natco Pharma Acquires 35.75% Stake in Adcock Ingram for $226 M
13 Nov 2025 //
INDPHARMAPOST
Natco Pharma Acquiring Stake In South African Adcock Ingram
11 Oct 2025 //
ECONOMICTIMES
NATCO Pharma Announces Adcock Ingram Acquisition Update
12 Sep 2025 //
INDPHARMAPOST
Natco Pharma Offers to Acquire Stake in Adcock Ingram Holdings
25 Jul 2025 //
EXPRESS PHARMA
Natco Appoints Bhimrao Jadhav As Senior VP - Operations
04 Mar 2025 //
INDPHARMAPOST
Natco Pharma Ltd soars 1.69%
25 Feb 2025 //
BUSINESS STD
Natco Pharma Drops for 10th Day, Falls 40% on Weak Q3
20 Feb 2025 //
BUSINESS STD
Natco Pharma shares tank 19%, near 52-week low on weak Q3 results
13 Feb 2025 //
BUSINESS STD
Natco Pharma slips as Q3 PAT slides 38% YoY to Rs 132 cr
13 Feb 2025 //
BUSINESS STD
Natco Pharma Ltd drops for fifth straight session
13 Feb 2025 //
BUSINESS STD
Natco Pharma Ltd leads losers in `A` group
13 Feb 2025 //
BUSINESS STD
Natco Pharma Net Profit Declines 37.47% In Q3
12 Feb 2025 //
BUSINESS STD
Natco Pharma Ltd soars 3.15%, up for third straight session
06 Feb 2025 //
BUSINESS STD
Natco Pharma Ltd gains for third straight session
19 Dec 2024 //
BUSINESS STD
Natco Pharma Ltd soars 1.05%, Gains for third straight session
03 Dec 2024 //
BUSINESS STD
Natco Pharma sells Telangana land for Rs 116 crore
28 Nov 2024 //
BUSINESS STD
Natco Pharma acquires 40 million shares in eGenesis Inc
04 Sep 2024 //
ECONOMICTIMES
Natco Pharma Q1 profit up 59 pc at Rs 668 cr
12 Aug 2024 //
ECONOMICTIMES
Natco Pharma Completes Transition of DASH Pharmaceuticals into Natco Pharma
02 Jan 2024 //
BUSINESSWIRE
Natco Pharma and Breckenridge dismissed from antitrust lawsuit
21 Dec 2023 //
INDIAN PHARMA POST
Operations disrupted at NATCO Pharma`s Manali, Chennai factory
08 Dec 2023 //
INDIAN PHARMA POST
Natco Pharma posts consolidated Q2F Y24 PAT of Rs. 369 Cr
15 Nov 2023 //
INDIAN PHARMA POST
Teva and Natco Announce Launch of additional strengths for Revlimid
09 Mar 2023 //
BUSINESSWIRE
HC reserves order on Natco`s plea over patent for Novartis drug
11 Jan 2023 //
ECONOMIC TIMES
Zhongchao Announces Drug Distributorship in China of Indian Drugs of Natco
04 Jan 2023 //
PR NEWSWIRE
Top Novartis cardiac drug to go off patent
03 Dec 2022 //
ECONOMICTIMES
NATCO launches Chlorantraniliprole combination agro products in India
04 Oct 2022 //
INDIANPHARMAPOST
Natco Cancer centre adopts Dozee, Contactless Continuous Remote Patient
12 Sep 2022 //
PHARMABIZ
NATCO cancer centre adopts Dozee`s RPM technology for cancer patients
09 Sep 2022 //
ECONOMIC TIMES
NATCO Pharma to sell stake in Nativita and assets of Pharma division
05 Sep 2022 //
INDIAINFOLINE
Natco Pharma`s partner Breckenridge gets FDA nod for prostate cancer drug
25 Jul 2022 //
ECONOMIC TIMES
J&J, Momenta Pharma file patent infringement lawsuit against Natco, Mylan
26 May 2022 //
BUSINESS-STANDARD
Natco, Biophore Pharma get nod to manufacture, market molnupiravir
20 Jan 2022 //
BUSINESSLINE
Natco Pharma signs pact with MPP to sell Molnupiravir capsules
20 Jan 2022 //
ECONOMIC TIMES
Natco acquires Dash Pharma for $18 million
04 Jan 2022 //
TIMESOFINDIA
Natco Pharma plans to launch Molnupiravir capsules this week
29 Dec 2021 //
EXPRESSPHARMA
Natco Pharma to launch Molnupiravir capsules this week for treatment of COVID-19
28 Dec 2021 //
ECONOMICTIMES
India’s NATCO Positioned to Acquire New Jersey Pharma Sales Operation Dash
17 Dec 2021 //
TRIALSITENEWS
Natco Pharma to acquire Dash Pharmaceuticals
17 Dec 2021 //
PHARMABIZ
NATCO Pharma launches Tipanat tablets for advanced colorectal, gastric cancer
23 Nov 2021 //
INDIAINFOLINE
Natco Pharma launches Tipanat tabs for colorectal and gastric cancer
18 Nov 2021 //
PHARMABIZ
Delhi HC restrains generic firms from making, selling patent drug of Novartis
03 Nov 2021 //
ECONOMICTIMES
Natco and Hetero awaits approval from DCGI on molnupiravir
30 Oct 2021 //
PHARMABIZ
Breckenridge Pharma launches generic Afinitor in US market
01 Oct 2021 //
PHARMABIZ
Dr Reddy`s, Natco Pharma Launch Generic Cancer Drug In Canada
02 Sep 2021 //
BUSINESS STANDARD
Natco Pharma (Canada) Inc. announces the launch of (Pr)NAT-LENALIDOMIDE Capsules
01 Sep 2021 //
NEWSWIRE
AbbVie Says Court Rules Imbruvica Patents Valid in Generic Challenge
21 Aug 2021 //
MORNING STAR
Natco Pharma stock dips more than 4% over verdict on patent litigation
20 Aug 2021 //
INDIAINFOLINE
Pharma shares under pressure; Aurobindo, Wockhardt, Hikal, Natco down 6%
20 Aug 2021 //
BUSINESS STANDARD
NATCO transfers Lenalidomide ANDA to Arrow
03 Aug 2021 //
BUSINESS-STANDARD
Breckenridge Announces Approval of its ANDA for Carfilzomib Intravenous Powder
16 Jun 2021 //
BIOSPACE
NATCO receives approval for Carfilzomib Vials ANDA
14 Jun 2021 //
BUSINESS STANDARD
Natco Pharma surges 20%, hits new high on USFDA nod for cancer drug
24 May 2021 //
BUSINESS-STANDARD
Natco Pharma Initiates Molnupiravir Phase 3 Trials
21 May 2021 //
BUSINESSWORLD
NATCO signs Voluntary Licensing Agreement with Lilly for Baricitinib for Covid-19 in India
17 May 2021 //
PRESS RELEASE
Covid drug: Natco eyes patent waiver
06 May 2021 //
ECONOMICTIMES
NATCO receives Emergency Use approval for Baricitinib tablets for Covid-19
04 May 2021 //
PRESS RELEASE
Natco Pharma seeks emergency approval of molnupiravir capsules
26 Apr 2021 //
PRESS RELEASE
Natco Pharma seeks approval for Covid drug candidate Molnupiravir
26 Apr 2021 //
LIVEMINT
Natco Pharma’s partner Alvogen gets US FDA tentative approval for generic
13 Apr 2021 //
PHARMBIZ
